Investigation of key miRNAs and target genes in bladder cancer using miRNA profiling and bioinformatic tools
- 935 Downloads
Despite the association of several miRNAs with bladder cancer, little is known about the miRNAs’ regulatory networks. In this study, we aimed to construct potential networks of bladder-cancer-related miRNAs and their known target genes using miRNA expression profiling and bioinformatics tools and to investigate potential key molecules that might play roles in bladder cancer regulatory networks. Global miRNA expression profiles were obtained using microarray followed by RT-qPCR validation using two randomly selected miRNAs. Known targets of deregulated miRNAs were utilized using DIANA-TarBase database v6.0. The incorporation of deregulated miRNAs and target genes into KEGG pathways were utilized using DIANA-mirPath software. To construct potential miRNA regulatory networks, the overlapping parts of three selected KEGG pathways were visualized by Cytoscape software. We finally gained 19 deregulated miRNAs, including 5 ups- and 14 down regulated in 27 bladder-cancer tissue samples and 8 normal urothelial tissue samples. The enrichment results of deregulated miRNAs and known target genes showed that most pathways were related to cancer or cell signaling pathways. We determined the hub CDK6, BCL2, E2F3, PTEN, MYC, RB, and ERBB3 target genes and hub hsa-let-7c, hsa-miR-195-5p, hsa-miR-141-3p, hsa-miR-26a-5p, hsa-miR-23b-3p, and hsa-miR-125b-5p miRNAs of the constructed networks. These findings provide new insights into the bladder cancer regulatory networks and give us a hypothesis that hsa-let-7c, hsa-miR-195-5p, and hsa-miR-125b-5p, along with CDK4 and CDK6 genes might exist in the same bladder cancer pathway. Particularly, hub miRNAs and genes might be potential biomarkers for bladder cancer clinics.
KeywordsBladder cancer miRNA Bioinformation KEGG pathways CDK4 CDK6
This research was supported by the Eskisehir Osmangazi University Research Fund with Grant no. 200811031. We are also thankful to Ece TURKMEN, the Product Manager at SEM Laboratuar Cihazlari Paz. San. Tic. A. S, (Istanbul-Turkey), who provided facilities to carry out this study.
- 1.Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray, F (2013) GLOBOCAN 2012 v1.0, Cancer incidence and mortality worldwide: IARC cancerbase No. 11 Lyon, France: international agency for research on cancer. Available from: http://globocan.iarc.fr, accessed on 04/06/2014.
- 11.Puerta-Gil P, Garcia-Baquero R, Jia AY, Ocana S, Alvarez-Mugica M, Alvarez-Ossorio JL, Cordon-Cardo C, Cava F, Sanchez-Carbayo M (2012) miR-143, miR-222, and miR-452 are useful as tumor stratification and noninvasive diagnostic biomarkers for bladder cancer. Am J Pathol 180:1808–1815CrossRefPubMedGoogle Scholar
- 13.Wang S, Hu J, Zhang D, Li J, Fei Q, Sun Y (2014) Prognostic role of microRNA-31 in various cancers: a meta-analysis.Tumour Biol. [Epub ahead of print]Google Scholar
- 14.Fu W, Pang L, Chen Y, Yang L, Zhu J, Wei Y (2014) The MicroRNAs as prognostic biomarkers for survival in esophageal cancer: a meta-analysis. Sci World J. 2014: 523979. Epub 2014 Jul 6. Review.Google Scholar
- 15.Vergoulis T, Vlachos IS, Alexiou P, , Georgakilas G, , Maragkakis M, Reczko M, Gerangelos S, Koziris N, Dalamagas T, Hatzigeorgiou AG (2012) Tarbase 6.0: capturing the exponential growth of miRNA targets with experimental support. Nucl Acids Res 40(D1):D222–D229. doi: 10.1093/nar/gkr1161 PubMedCentralCrossRefPubMedGoogle Scholar
- 16.Vlachos IS, Kostoulas N, Vergoulis T, Georgakilas G, Reczko M, Maragkakis M, Paraskevopoulou MD, Prionidis K, Dalamagas T, Hatzigeorgiou AG (2012) DIANA miRPath v.2.0: investigating the combinatorial effect of microRNAs in pathways nucleic acids research (Web server issue)Google Scholar
- 18.Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Series B Stat Methodol 57:289–300Google Scholar
- 22.Abdollahi A, Schwager C, Kleeff J, Esposito I, Domhan S, Peschke P, Hauser K, Hahnfeldt P, Hlatky L, Debus J, Peters JM, Friess H, Folkman J, Huber PE (2007) Transcriptional network governing the angiogenic switch in human pancreatic cancer. Proc Natl Acad Sci USA 104(31):12890–12895 Epub 2007 Jul 24PubMedCentralCrossRefPubMedGoogle Scholar
- 23.Horvath S, Zhang B, Carlson M, Lu KV, Zhu S, Felciano RM, Laurance MF, Zhao W, Qi S, Chen Z, Lee Y, Scheck AC, Liau LM, Wu H, Geschwind DH, Febbo PG, Kornblum HI, Cloughesy TF, Nelson SF, Mischel PS (2006) Analysis of oncogenic signaling networks in glioblastoma identifies ASPM as a molecular target. Proc Natl Acad Sci USA 103(46):17402–17407 Epub 2006 Nov 7PubMedCentralCrossRefPubMedGoogle Scholar
- 24.Castillo-Martin M, Domingo-Domenech J, Karni-Schmidt O, Matos T, Cordon-Cardo C (2010) Molecular pathways of urothelial development and bladder tumorigenesis. UrolOncol 28(4): 401–8. doi: 10.1016/j.urolonc.2009.04.019. Review.